Skip to content

Public FDA record

Z-1739-2025: Atalante X, Powered Exoskeleton. Atalante X is intended to perform ambulatory functions and mobility exe

Recall record Z-1739-2025 for WANDERCRAFT SAS. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1739-2025
Company in FDA record
WANDERCRAFT SAS
FDA classification date
May 8, 2025
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Potential for exoskeleton to lose lateral balance and cause patient to fall.

Source facts

Action
An URGENT SAFETY NOTICE dated 4/3/25 was mailed to consignees. The letter notifies consignees that WANDERCRAFT will be reinforcing their training program for the Atalante X and providing additional instructions by 5/1/25. Until the additional instructions can be provided, users are being instructed to only have certified Atalante X operators maintain the stability of the exoskeleton at all times by keeping at least one hand on the handles throughout the session. Consignees are to share the recall notification with users at their facility and retained for awareness.
Initiated
2025-04-03
Root cause
Use error
Distribution
Domestic: PA & NY.
Recall number
Z-1739-2025
Recall status
Open, Classified
CDRH record ID
213308
FDA classified
2025-05-08
Recall event number
96635

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗